Infection Control and the Prevention of Nosocomial Infections in the Intensive Care Unit

ABSTRACT

Nosocomial infections continue to be significant causes of morbidity, mortality, and added costs in the health care setting. Half of all life-threatening nosocomial bloodstream infections and pneumonias occur in intensive care units (ICUs), despite ICUs representing only 15 to 20% of all hospital beds. Thus an efficient focus for prevention and control of life-threatening health care-associated infections should be in ICUs. Further, growing antibiotic resistance complicates the therapy of serious infections. Meticulous infection control practice with continued attention to hand hygiene is of paramount importance. Strict adherence to evidence-based catheter insertion and maintenance policies reduces nosocomial bloodstream infections. Evidence-based prevention strategies for ventilator-associated pneumonia, including management of respiratory equipment according to published guidelines and maintaining backrest elevation at 30 to 45 degrees, are effective. For greatest risk reduction, multifaceted programs ensuring maximal adherence with evidence-based infection control guidelines are needed.

KEYWORDS

Nosocomial infections - bloodstream infections - ventilator-associated pneumonia - infection control

REFERENCES

• 1 Wenzel R P. Perspective: attributable mortality-the promise of better antimicrobial therapy.  J Infect Dis. 1998;  178 917-919
• 2 Wenzel R P, Edmond M B. The impact of hospital-acquired bloodstream infections.  Emerg Infect Dis. 2001;  7 174-177
• 3 Wisplinghoff H, Bischoff T, Tallent S M, Seifert H, Wenzel R P, Edmond M B. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.  Clin Infect Dis. 2004;  39 309-317
• 4 Landry S L, Kaiser D L, Wenzel R P. Hospital stay and mortality attributed to nosocomial enterococcal bacteremia: a controlled study.  Am J Infect Control. 1989;  17 323-329
• 5 Wey S B, Mori M, Pfaller M A, Woolson R F, Wenzel R P. Hospital-acquired candidemia: the attributable mortality and excess length of stay.  Arch Intern Med. 1988;  148 2642-2645
• 6 Martin M A, Pfaller M A, Wenzel R P. Coagulase-negative staphylococcal bacteremia: mortality and hospital stay.  Ann Intern Med. 1989;  110 9-16
• 7 Pittet D, Tarara D, Wenzel R P. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality.  JAMA. 1994;  271 1598-1601
• 8 Jones M E, Draghi D C, Thornsberry C, Karlowsky J A, Sahm D F, Wenzel R P. Emerging resistance among bacterial pathogens in the intensive care unit: a European and North American Surveillance study (2000-2002).  Ann Clin Microbiol Antimicrob. 2004;  3 14
• 9 Wenzel R P, Sahm D F, Thornsberry C, Draghi D C, Jones M E, Karlowsky J A. In vitro susceptibilities of gram-negative bacteria isolated from hospitalized patients in four European countries, Canada, and the United States in 2000-2001 to expanded-spectrum cephalosporins and comparator antimicrobials: implications for therapy.  Antimicrob Agents Chemother. 2003;  47 3089-3098
• 10 Ibrahim E H, Sherman G, Ward S, Fraser V J, Kollef M H. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting.  , [see comments] Chest. 2000;  118 146-155
• 11 Miller P J, Searcy M A, Kaiser D L, Wenzel R P. The relationship between surgeon experience and endometritis after cesarean section.  Surg Gynecol Obstet. 1987;  165 535-539
• 12 Gudlaugsson O, Gillespie S, Lee K et al.. Attributable mortality of nosocomial candidemia, revisited.  Clin Infect Dis. 2003;  37 1172-1177
• 13 Pfaller M A, Messer S A, Boyken L et al.. In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program.  Diagn Microbiol Infect Dis. 2004;  48 201-205
• 14 Wenzel R P, Gennings C. Bloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategies.  Clin Infect Dis. 2005;  41(Suppl 6) S389-S393
• 15 Franchi D, Climo M W, Wong A H, Edmond M B, Wenzel R P. Seeking vancomycin resistant Staphylococcus aureus among patients with vancomycin-resistant enterococci.  Clin Infect Dis. 1999;  29 1566-1568
• 16 Richards M J, Edwards J R, Culver D H, Gaynes R P. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System.  Crit Care Med. 1999;  27 887-892
• 17 Rojo D, Pinedo A, Clavijo E, Garcia-Rodriguez A, Garcia V. Analysis of risk factors associated with nosocomial bacteraemias.  J Hosp Infect. 1999;  42 135-141
• 18 Digiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit.  Am J Respir Crit Care Med. 1999;  160 976-981
• 19 Rello J, Ochagavia A, Sabanes E et al.. Evaluation of outcome of intravenous catheter-related infections in critically ill patients.  Am J Respir Crit Care Med. 2000;  162 1027-1030
• 20 Soufir L, Timsit J F, Mahe C, Carlet J, Regnier B, Chevret S. Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study.  Infect Control Hosp Epidemiol. 1999;  20 396-401
• 21 Dimick J B, Pelz R K, Consunji R, Swoboda S M, Hendrix C W, Lipsett P A. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit.  Arch Surg. 2001;  136 229-234
• 22 Mermel L A. Prevention of intravascular catheter-related infections.  Ann Intern Med. 2000;  132 391-402
• 23 Saint S, Veenstra D L, Lipsky B A. The clinical and economic consequences of nosocomial central venous catheter-related infection: are antimicrobial catheters useful?.  Infect Control Hosp Epidemiol. 2000;  21 375-380
• 24 O'Grady N P, Alexander M, Dellinger E P et al.. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention.  MMWR Recomm Rep. 2002;  51 1-29
• 25 Sessler C N. Preventing mechanical and infectious complications of central venous catheterization. In: Vincent JL Yearbook of Intensive Care and Emergency Medicine. Berlin; Springer 2004: 544-557
• 26 Saint S. Prevention of intravascular catheter-associated infections. http://www.ahrq.gov/clinic/ptsafety/chap16a.htm 2001
• 27 Eggimann P, Pittet D. Infection control in the ICU.  Chest. 2001;  120 2059-2093
• 28 Raad I I, Hohn D C, Gilbreath B J et al.. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion.  Infect Control Hosp Epidemiol. 1994;  15 231-238
• 29 Chaiyakunapruk N, Veenstra D L, Lipsky B A, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis.  Ann Intern Med. 2002;  136 792-801
• 30 Cobb D K, High K P, Sawyer R G et al.. A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters.  N Engl J Med. 1992;  327 1062-1068
• 31 Cook D, Randolph A, Kernerman P et al.. Central venous catheter replacement strategies: a systematic review of the literature.  Crit Care Med. 1997;  25 1417-1424
• 32 Ruesch S, Walder B, Tramer M R. Complications of central venous catheters: internal jugular versus subclavian access-a systematic review.  Crit Care Med. 2002;  30 454-460
• 33 Heard S O, Wagle M, Vijayakumar E et al.. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter- related bacteremia.  Arch Intern Med. 1998;  158 81-87
• 34 Goetz A M, Wagener M M, Miller J M, Muder R R. Risk of infection due to central venous catheters: effect of site of placement and catheter type.  Infect Control Hosp Epidemiol. 1998;  19 842-845
• 35 Merrer J, De Jonghe B, Golliot F et al.. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial.  JAMA. 2001;  286 700-707
• 36 Deshpande K S, Hatem C, Ulrich H L et al.. The incidence of infectious complications of central venous catheters at the subclavian, internal jugular, and femoral sites in an intensive care unit population.  Crit Care Med. 2005;  33 13-20 discussion 234-235
• 37 Durbec O, Viviand X, Potie F, Vialet R, Albanese J, Martin C. A prospective evaluation of the use of femoral venous catheters in critically ill adults.  Crit Care Med. 1997;  25 1986-1989
• 38 Lorente L, Villegas J, Martin M M, Jimenez A, Mora M L. Catheter-related infection in critically ill patients.  Intensive Care Med. 2004;  30 1681-1684
• 39 Wall R J, Ely E W, Elasy T A et al.. Using real-time process measurements to reduce catheter related bloodstream infections in the intensive care unit.  Qual Saf Health Care. 2005;  14 295-302
• 40 Reduction in central line-associated bloodstream infections among patients in intensive care units: Pennsylvania, April 2001-March 2005.  MMWR Morb Mortal Wkly Rep. 2005;  54 1013-1016
• 41 Berenholtz S M, Pronovost P J, Lipsett P A et al.. Eliminating catheter-related bloodstream infections in the intensive care unit.  Crit Care Med. 2004;  32 2014-2020
• 42 Hind D, Calvert N, McWilliams R et al.. Ultrasonic locating devices for central venous cannulation: meta-analysis.  BMJ. 2003;  327 361-364
• 43 Milling Jr T J, Rose J, Briggs W M et al.. Randomized, controlled clinical trial of point-of-care limited ultrasonography assistance of central venous cannulation: The Third Sonography Outcomes Assessment Program (SOAP-3) Trial.  Crit Care Med. 2005;  33 1764-1769
• 44 Casey A L, Worthington T, Lambert P A, Quinn D, Faroqui M H, Elliott T S. A randomized, prospective clinical trial to assess the potential infection risk associated with the PosiFlow needleless connector.  J Hosp Infect. 2003;  54 288-293
• 45 Eggimann P, Harbarth S, Constantin M N, Touveneau S, Chevrolet J C, Pittet D. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care.  Lancet. 2000;  355 1864-1868
• 46 Sherertz R J, Ely E W, Westbrook D M et al.. Education of physicians-in-training can decrease the risk for vascular catheter infection.  Ann Intern Med. 2000;  132 641-648
• 47 Coopersmith C M, Rebmann T L, Zack J E et al.. Effect of an education program on decreasing catheter-related bloodstream infections in the surgical intensive care unit.  Crit Care Med. 2002;  30 59-64
• 48 Higuera F, Rosenthal V D, Duarte P, Ruiz J, Franco G, Safdar N. The effect of process control on the incidence of central venous catheter-associated bloodstream infections and mortality in intensive care units in Mexico.  Crit Care Med. 2005;  33 2022-2027
• 49 Martin M, Scalabrini B, Rioux A, Xhignesse M A. Training fourth-year medical students in critical invasive skills improves subsequent patient safety.  Am Surg. 2003;  69 437-440
• 50 Sessler C N, Perry J, Sampson R, Edmond M B. CD-ROM-based program for medical student and housestaff education regarding central venous catheter procedure and prevention of complications [abstract].  Crit Care Med. 2005;  32 A67
• 51 Veenstra D L, Saint S, Saha S, Lumley T, Sullivan S D. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis.  JAMA. 1999;  281 261-267
• 52 Darouiche R O, Raad I I, Heard S O et al.. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. [see comments].  N Engl J Med. 1999;  340 1-8
• 53 Rupp M E, Lisco S J, Lipsett P A et al.. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial.  Ann Intern Med. 2005;  143 570-580
• 54 Brun-Buisson C, Doyon F, Sollet J P, Cochard J F, Cohen Y, Nitenberg G. Prevention of intravascular catheter-related infection with newer chlorhexidine-silver sulfadiazine-coated catheters: a randomized controlled trial.  Intensive Care Med. 2004;  30 837-843
• 55 Corral L, Nolla-Salas M, Ibanez-Nolla J et al.. A prospective, randomized study in critically ill patients using the Oligon Vantex catheter.  J Hosp Infect. 2003;  55 212-219
• 56 Moretti E W, Ofstead C L, Kristy R M, Wetzler H P. Impact of central venous catheter type and methods on catheter-related colonization and bacteraemia.  J Hosp Infect. 2005;  61 139-145
• 57 Ranucci M, Isgro G, Giomarelli P P et al.. Impact of oligon central venous catheters on catheter colonization and catheter-related bloodstream infection.  Crit Care Med. 2003;  31 52-59
• 58 Shorr A F, Humphreys C W, Helman D L. New choices for central venous catheters: potential financial implications.  Chest. 2003;  124 275-284
• 59 Levy I, Katz J, Solter E et al.. Chlorhexidine-impregnated dressing for prevention of colonization of central venous catheters in infants and children: a randomized controlled study.  Pediatr Infect Dis J. 2005;  24 676-679
• 60 Carratala J, Niubo J, Fernandez-Sevilla A et al.. Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer.  Antimicrob Agents Chemother. 1999;  43 2200-2204
• 61 Leon C, Alvarez-Lerma F, Ruiz-Santana S et al.. Antiseptic chamber-containing hub reduces central venous catheter-related infection: a prospective, randomized study.  Crit Care Med. 2003;  31 1318-1324
• 62 Appelgren P, Ransjo U, Bindslev L, Espersen F, Larm O. Surface heparinization of central venous catheters reduces microbial colonization in vitro and in vivo: results from a prospective, randomized trial.  Crit Care Med. 1996;  24 1482-1489
• 63 Randolph A G, Cook D J, Gonzales C A, Brun-Buisson C. Tunneling short-term central venous catheters to prevent catheter- related infection: a meta-analysis of randomized, controlled trials.  Crit Care Med. 1998;  26 1452-1457
• 64 Timsit J F, Bruneel F, Cheval C et al.. Use of tunneled femoral catheters to prevent catheter-related infection: a randomized, controlled trial.  Ann Intern Med. 1999;  130 729-735
• 65 Safdar N, Maki D G. Risk of catheter-related bloodstream infection with peripherally inserted central venous catheters used in hospitalized patients.  Chest. 2005;  128 489-495
• 66 Garibaldi R A, Mooney B R, Epstein B J, Britt M R. An evaluation of daily bacteriologic monitoring to identify preventable episodes of catheter-associated urinary tract infection.  Infect Control. 1982;  3 466-470
• 67 Stark R P, Maki D G. Bacteriuria in the catheterized patient. What quantitative level of bacteriuria is relevant?.  N Engl J Med. 1984;  311 560-564
• 68 Maki D G. Nosocomial bacteremia: an epidemiologic overview.  Am J Med. 1981;  70 719-732
• 69 Maki D G, Tambyah P A. Engineering out the risk for infection with urinary catheters.  Emerg Infect Dis. 2001;  7 342-347
• 70 Safdar N, Dezfulian C, Collard H R, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review.  Crit Care Med. 2005;  33 2184-2193
• 71 Langer M, Cigada M, Mandelli M, Mosconi P, Tognoni G. Early onset pneumonia: a multicenter study in intensive care units.  Intensive Care Med. 1987;  13 342-346
• 72 Pugin J, Auckenthaler R, Mili N, Janssens J P, Lew P D, Suter P M. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic “blind” bronchoalveolar lavage fluid.  Am Rev Respir Dis. 1991;  143 1121-1129
• 73 Driks M R, Craven D E, Celli B R et al.. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers: the role of gastric colonization.  N Engl J Med. 1987;  317 1376-1382
• 74 Prod'hom G, Leuenberger P, Koerfer J et al.. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer: a randomized controlled trial.  Ann Intern Med. 1994;  120 653-662
• 75 American Thoracic Society . Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.  Am J Respir Crit Care Med. 2005;  171 388-416
• 76 Fagon J Y, Chastre J, Hance A J, Montravers P, Novara A, Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay.  Am J Med. 1993;  94 281-288
• 77 Kollef M H. Ventilator-associated pneumonia: a multivariate analysis.  JAMA. 1993;  270 1965-1970
• 78 Kollef M H, Silver P, Murphy D M, Trovillion E. The effect of late-onset ventilator-associated pneumonia in determining patient mortality.  Chest. 1995;  108 1655-1662
• 79 Tablan O C, Anderson L J, Besser R, Bridges C, Hajjeh R. Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee.  MMWR Recomm Rep. 2004;  53 1-36
• 80 National Nosocomial Infections Surveillance (NNIS) System Report . Data summary from January 1992 through June 2004, issued October 2004.  Am J Infect Control. 2004;  32 470-485
• 81 Chevret S, Hemmer M, Carlet J, Langer M. Incidence and risk factors of pneumonia acquired in intensive care units: results from a multicenter prospective study on 996 patients. European Cooperative Group on Nosocomial Pneumonia.  Intensive Care Med. 1993;  19 256-264
• 82 Haley R W. Nosocomial infections in surgical patients: developing valid measures of intrinsic patient risk.  Am J Med. 1991;  91 145S-151S
• 83 Celis R, Torres A, Gatell J M, Almela M, Rodriguez-Roisin R, Agusti-Vidal A. Nosocomial pneumonia: a multivariate analysis of risk and prognosis.  Chest. 1988;  93 318-324
• 84 George D L. Epidemiology of nosocomial pneumonia in intensive care unit patients.  Clin Chest Med. 1995;  16 29-44
• 85 Kollef M H. The prevention of ventilator-associated pneumonia.  N Engl J Med. 1999;  340 627-634
• 86 Hixson S, Sole M L, King T. Nursing strategies to prevent ventilator-associated pneumonia.  AACN Clin Issues. 1998;  9 76-90 quiz 145-146
• 87 Tasota F J, Fisher E M, Coulson C F, Hoffman L A. Protecting ICU patients from nosocomial infections: practical measures for favorable outcomes.  Crit Care Nurse. 1998;  18 54-65 quiz 66-57
• 88 Craven D E, Kunches L M, Kilinsky V, Lichtenberg D A, Make B J, McCabe W R. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation.  Am Rev Respir Dis. 1986;  133 792-796
• 89 Kollef M H. The identification of ICU-specific outcome predictors: a comparison of medical, surgical, and cardiothoracic ICUs from a single institution.  Heart Lung. 1995;  24 60-66
• 90 Torres A, Serra-Batlles J, Ros E et al.. Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: the effect of body position.  Ann Intern Med. 1992;  116 540-543
• 91 Orozco-Levi M, Torres A, Ferrer M et al.. Semirecumbent position protects from pulmonary aspiration but not completely from gastroesophageal reflux in mechanically ventilated patients.  Am J Respir Crit Care Med. 1995;  152 1387-1390
• 92 Drakulovic M B, Torres A, Bauer T T, Nicolas J M, Nogue S, Ferrer M. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial.  Lancet. 1999;  354 1851-1858
• 93 Grap M J, Munro C L, Hummel 3rd R S, Elswick Jr R K, McKinney J L, Sessler C N. Effect of backrest elevation on the development of ventilator-associated pneumonia.  Am J Crit Care. 2005;  14 325-332 quiz 333
• 94 Evans D. The use of position during critical illness: current practice and review of the literature.  Aust Crit Care. 1994;  7 16-21
• 95 Grap M J, Cantley M, Munro C L, Corley M C. Use of backrest elevation in critical care: a pilot study.  Am J Crit Care. 1999;  8 475-480
• 96 Grap M J, Munro C L, Bryant S, Ashtiani B. Predictors of backrest elevation in critical care.  Intensive Crit Care Nurs. 2003;  19 68-74
• 97 Grap M J, Munro C L. Quality improvement in backrest elevation: improving outcomes in critical care.  AACN Clin Issues. 2005;  16 133-139
• 98 Helman Jr D L, Sherner III J H, Fitzpatrick T M, Callender M E, Shorr A F. Effect of standardized orders and provider education on head-of-bed positioning in mechanically ventilated patients.  Crit Care Med. 2003;  31 2285-2290
• 99 Levine S A, Niederman M S. The impact of tracheal intubation on host defenses and risks for nosocomial pneumonia.  Clin Chest Med. 1991;  12 523-543
• 100 Aebert H, Hunefeld G, Regel G. Paranasal sinusitis and sepsis in ICU patients with nasotracheal intubation.  Intensive Care Med. 1988;  15 27-30
• 101 Grindlinger G A, Niehoff J, Hughes S L, Humphrey M A, Simpson G. Acute paranasal sinusitis related to nasotracheal intubation of head-injured patients.  Crit Care Med. 1987;  15 214-217
• 102 Salord F, Gaussorgues P, Marti-Flich J et al.. Nosocomial maxillary sinusitis during mechanical ventilation: a prospective comparison of orotracheal versus the nasotracheal route for intubation.  Intensive Care Med. 1990;  16 390-393
• 103 Torres A, Aznar R, Gatell J M et al.. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients.  Am Rev Respir Dis. 1990;  142 523-528
• 104 Torres A, Gatell J M, Aznar E et al.. Re-intubation increases the risk of nosocomial pneumonia in patients needing mechanical ventilation.  Am J Respir Crit Care Med. 1995;  152 137-141
• 105 Dezfulian C, Shojania K, Collard H R, Kim H M, Matthay M A, Saint S. Subglottic secretion drainage for preventing ventilator-associated pneumonia: a meta-analysis.  Am J Med. 2005;  118 11-18
• 106 Kollef M H, Skubas N J, Sundt T M. A randomized clinical trial of continuous aspiration of subglottic secretions in cardiac surgery patients.  Chest. 1999;  116 1339-1346
• 107 Valles J, Artigas A, Rello J et al.. Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia.  Ann Intern Med. 1995;  122 179-186
• 108 Fourrier F, Duvivier B, Boutigny H, Roussel-Delvallez M, Chopin C. Colonization of dental plaque: a source of nosocomial infections in intensive care unit patients.  Crit Care Med. 1998;  26 301-308
• 109 Fourrier F, Cau-Pottier E, Boutigny H, Roussel-Delvallez M, Jourdain M, Chopin C. Effects of dental plaque antiseptic decontamination on bacterial colonization and nosocomial infections in critically ill patients.  Intensive Care Med. 2000;  26 1239-1247
• 110 Collard H R, Saint S, Matthay M A. Prevention of ventilator-associated pneumonia: an evidence-based systematic review.  Ann Intern Med. 2003;  138 494-501
• 111 Duncan R A, Steger K A, Craven D E. Selective decontamination of the digestive tract: risks outweigh benefits for intensive care unit patients.  Semin Respir Infect. 1993;  8 308-324
• 112 Larson E L. APIC guideline for handwashing and hand antisepsis in health care settings.  Am J Infect Control. 1995;  23 251-269
• 113 Boyce J M, Pittet D. Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America.  MMWR Recomm Rep. 2002;  51 1-45 quiz CE41-44
• 114 Sproat L J, Inglis T J. A multicentre survey of hand hygiene practice in intensive care units.  J Hosp Infect. 1994;  26 137-148
• 115 Sanford M D, Widmer A F, Bale M J, Jones R N, Wenzel R P. Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus .  Clin Infect Dis. 1994;  19 1123-1128
• 116 Bertone S A, Fisher M C, Mortensen J E. Quantitative skin cultures at potential catheter sites in neonates.  Infect Control Hosp Epidemiol. 1994;  15 315-318
• 117 Bonten M J, Hayden M K, Nathan C et al.. Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci.  Lancet. 1996;  348 1615-1619
• 118 Larson E L, Cronquist A B, Whittier S, Lai L, Lyle C T, Della Latta P. Differences in skin flora between inpatients and chronically ill outpatients.  Heart Lung. 2000;  29 298-305
• 119 Winnefeld M, Richard M A, Drancourt M, Grob J J. Skin tolerance and effectiveness of two hand decontamination procedures in everyday hospital use.  Br J Dermatol. 2000;  143 546-550
• 120 Boyce J M, Kelliher S, Vallande N. Skin irritation and dryness associated with two hand-hygiene regimens: soap-and-water hand washing versus hand antisepsis with an alcoholic hand gel.  Infect Control Hosp Epidemiol. 2000;  21 442-448
• 121 Wade J J, Casewell M W. The evaluation of residual antimicrobial activity on hands and its clinical relevance.  J Hosp Infect. 1991;  18(Suppl B) 23-28
• 122 Doebbeling B N, Stanley G L, Sheetz C T et al.. Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units.  N Engl J Med. 1992;  327 88-93
• 123 Bischoff W E, Reynolds T M, Sessler C N, Edmond M B, Wenzel R P. Handwashing compliance by health care workers: the impact of introducing an accessible, alcohol-based hand antiseptic.  Arch Intern Med. 2000;  160 1017-1021
• 124 Maury E, Alzieu M, Baudel J L et al.. Availability of an alcohol solution can improve hand disinfection compliance in an intensive care unit.  Am J Respir Crit Care Med. 2000;  162 324-327
• 125 Muto C A, Sistrom M G, Farr B M. Hand hygiene rates unaffected by installation of dispensers of a rapidly acting hand antiseptic.  Am J Infect Control. 2000;  28 273-276
• 126 Kaplan L M, McGuckin M. Increasing handwashing compliance with more accessible sinks.  Infect Control. 1986;  7 408-410
• 127 Pittet D, Hugonnet S, Harbarth S et al.. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene: Infection Control Programme.  Lancet. 2000;  356 1307-1312
• 128 Doebbeling B N, Pfaller M A, Houston A K, Wenzel R P. Removal of nosocomial pathogens from the contaminated glove: implications for glove reuse and handwashing.  Ann Intern Med. 1988;  109 394-398
• 129 Kim P W, Roghmann M C, Perencevich E N, Harris A D. Rates of hand disinfection associated with glove use, patient isolation, and changes between exposure to various body sites.  Am J Infect Control. 2003;  31 97-103
• 130 Zachary K C, Bayne P S, Morrison V J, Ford D S, Silver L C, Hooper D C. Contamination of gowns, gloves, and stethoscopes with vancomycin-resistant enterococci.  Infect Control Hosp Epidemiol. 2001;  22 560-564
• 131 Boyce J M, Potter-Bynoe G, Chenevert C, King T. Environmental contamination due to methicillin-resistant Staphylococcus aureus: possible infection control implications.  Infect Control Hosp Epidemiol. 1997;  18 622-627
• 132 Boyce J M, Mermel L A, Zervos M J et al.. Controlling vancomycin-resistant enterococci.  Infect Control Hosp Epidemiol. 1995;  16 634-637
• 133 Srinivasan A, Song X, Ross T, Merz W, Brower R, Perl T M. A prospective study to determine whether cover gowns in addition to gloves decrease nosocomial transmission of vancomycin-resistant enterococci in an intensive care unit.  Infect Control Hosp Epidemiol. 2002;  23 424-428
• 134 Pelke S, Ching D, Easa D, Melish M E. Gowning does not affect colonization or infection rates in a neonatal intensive care unit.  Arch Pediatr Adolesc Med. 1994;  148 1016-1020
• 135 Slaughter S, Hayden M K, Nathan C et al.. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit.  Ann Intern Med. 1996;  125 448-456
• 136 Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994. Centers for Disease Control and Prevention.  MMWR Morb Mortal Wkly Rep. 1994;  43 1-132
• 137 Evans H L, Shaffer M M, Hughes M G et al.. Contact isolation in surgical patients: a barrier to care?.  Surgery. 2003;  134 180-188
• 138 Stelfox H T, Bates D W, Redelmeier D A. Safety of patients isolated for infection control.  JAMA. 2003;  290 1899-1905
• 139 Saint S, Higgins L A, Nallamothu B K, Chenoweth C. Do physicians examine patients in contact isolation less frequently? A brief report.  Am J Infect Control. 2003;  31 354-356
• 140 Tarzi S, Kennedy P, Stone S, Evans M. Methicillin-resistant Staphylococcus aureus: psychological impact of hospitalization and isolation in an older adult population.  J Hosp Infect. 2001;  49 250-254
• 141 Catalano G, Houston S H, Catalano M C et al.. Anxiety and depression in hospitalized patients in resistant organism isolation.  South Med J. 2003;  96 141-145
• 142 Delgado-Rodriguez M, Gomez-Ortega A, Sillero-Arenas M, Martinez-Gallego G, Medina-Cuadros M, Llorca J. Efficacy of surveillance in nosocomial infection control in a surgical service.  Am J Infect Control. 2001;  29 289-294
• 143 Rubin H R, Pronovost P, Diette G B. The advantages and disadvantages of process-based measures of health care quality.  Int J Qual Health Care. 2001;  13 469-474
• 144 Evans D B, Edejer T T, Lauer J, Frenk J, Murray C J. Measuring quality: from the system to the provider.  Int J Qual Health Care. 2001;  13 439-446
• 145 Kritchevsky S B, Braun B I, Gross P A, Newcomb C S, Kelleher C A, Simmons B P. Definition and adjustment of Cesarean section rates and assessments of hospital performance.  Int J Qual Health Care. 1999;  11 283-291
• 146 Rosenthal V D, Guzman S, Safdar N. Reduction in nosocomial infection with improved hand hygiene in intensive care units of a tertiary care hospital in Argentina.  Am J Infect Control. 2005;  33 392-397
• 147 Rosenthal V D, Guzman S, Safdar N. Effect of education and performance feedback on rates of catheter-associated urinary tract infection in intensive care units in Argentina.  Infect Control Hosp Epidemiol. 2004;  25 47-50